| $385M | ||
| $337M | ||
| $100M | ||
| $87M | ||
| $82M | ||
| $62M |
Buys | $1,118,771 | 4 | 100 |
Sells | $0 | 0 | 0 |
| Thermopylae Holdings Ltd. | 10 percent owner | 1 | $742,243 | 0 | $0 | $742,243 |
| Montalbano John S. | director | 3 | $376,528 | 0 | $0 | $376,528 |
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Over the last 12 months, insiders at AbCellera Biologics Inc. have bought $1.12M and sold $0 worth of AbCellera Biologics Inc. stock.
On average, over the past 5 years, insiders at AbCellera Biologics Inc. have bought $30.26M and sold $394.03M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Thermopylae Holdings Ltd. (10 percent owner) — $742,243. Montalbano John S. (director) — $376,528.
The last purchase of 50,000 shares for transaction amount of $178,460 was made by Montalbano John S. (director) on 2025‑11‑26.
| 2025-11-26 | Montalbano John S. | director | 50,000 0.0164% | $3.57 | $178,460 | -2.67% | ||
| 2025-03-11 | Thermopylae Holdings Ltd. | 10 percent owner | 343,631 0.1117% | $2.16 | $742,243 | +70.40% | ||
| 2025-03-10 | Montalbano John S. | director | 25,000 0.0088% | $2.30 | $57,500 | +71.85% | ||
| 2025-03-06 | Montalbano John S. | director | 60,000 0.0198% | $2.34 | $140,568 | +57.91% | ||
| 2024-08-29 | Thermopylae Holdings Ltd. | 10 percent owner | 283,516 0.0993% | $2.61 | $739,977 | +10.08% | ||
| 2023-11-08 | Montalbano John S. | director | 10,000 0.0037% | $4.46 | $44,600 | -7.89% | ||
| 2023-11-06 | Montalbano John S. | director | 20,000 0.0071% | $4.64 | $92,800 | -13.76% | ||
| 2023-09-22 | Hayden Michael R | director | 20,000 0.0066% | $4.91 | $98,200 | -14.30% | ||
| 2023-09-12 | Lecault Veronique | Chief Operating Officer | 20,000 0.007% | $5.19 | $103,800 | -15.56% | ||
| 2023-08-08 | Hayden Michael R | director | 30,000 0.0104% | $5.90 | $177,000 | -23.77% | ||
| 2023-05-26 | Thermopylae Holdings Ltd. | 10 percent owner | 153,000 0.051% | $6.52 | $997,728 | -26.25% | ||
| 2023-05-26 | Booth Andrew | Chief Financial Officer | 14,500 0.0051% | $6.85 | $99,325 | -26.25% | ||
| 2022-12-16 | Thermopylae Holdings Ltd. | director | 85,102 0.0295% | $10.10 | $859,249 | -33.50% | ||
| 2022-08-19 | Thermopylae Holdings Ltd. | 10 percent owner | 200,000 0.0702% | $11.46 | $2.29M | -20.94% | ||
| 2022-06-14 | Thermopylae Holdings Ltd. | 10 percent owner | 9,173 0.0029% | $8.05 | $73,842 | +16.48% | ||
| 2022-06-13 | Thermopylae Holdings Ltd. | 10 percent owner | 54,915 0.0189% | $8.03 | $441,066 | +25.00% | ||
| 2022-06-06 | Thermopylae Holdings Ltd. | 10 percent owner | 64,545 0.0222% | $7.50 | $483,965 | +33.64% | ||
| 2022-05-16 | Lecault Veronique | Chief Operating Officer | 200,000 0.057% | $6.34 | $1.27M | +31.24% | ||
| 2022-05-13 | Thermopylae Holdings Ltd. | 10 percent owner | 300,000 0.1057% | $7.26 | $2.18M | +41.77% | ||
| 2022-05-12 | Thermopylae Holdings Ltd. | 10 percent owner | 1.41M 0.4723% | $6.41 | $9.02M | +52.76% |
| Thermopylae Holdings Ltd. | 10 percent owner | 56143640 18.7571% | $199.87M | 11 | 1 | +6.72% |
| Montalbano John S. | director | 221000 0.0738% | $786,760.00 | 9 | 0 | <0.0001% |
| THIEL PETER | director | 10179880 3.401% | $36.24M | 1 | 0 | <0.0001% |
| Lecault Veronique | Chief Operating Officer | 2040122 0.6816% | $7.26M | 4 | 1 | <0.0001% |
| Hayden Michael R | director | 1323397 0.4421% | $4.71M | 3 | 1 | <0.0001% |
| Hansen Carl L. G. | Chief Executive Officer | 233500 0.078% | $831,260.00 | 0 | 1 | |
| Booth Andrew | Chief Financial Officer | 153000 0.0511% | $544,680.00 | 3 | 1 | <0.0001% |
| HAMER JOHN | director | 128862 0.0431% | $458,748.72 | 0 | 2 | |
| Stimart Tryn | Chief Legal Officer | 250 0.0001% | $890.00 | 1 | 1 | <0.0001% |
| Falconer Ester | Chief Technology Officer | 0 0% | $0 | 0 | 1 |
$8,217,280 | 112 | 46.33% | $1.12B | |
$607,159,124 | 92 | 3.55% | $1.08B | |
$61,783,526 | 37 | 18.57% | $1.08B | |
AbCellera Biologics Inc. (ABCL) | $150,196,329 | 28 | -8.09% | $1.07B |
$7,598,498 | 27 | 34.68% | $1.03B | |
$103,156,698 | 27 | 19.10% | $1.01B | |
$49,750,490 | 17 | 37.19% | $1.04B | |
$276,750,010 | 16 | -7.95% | $1.13B | |
$2,788,839 | 12 | 6.73% | $1.16B | |
$18,336,420 | 12 | 24.03% | $1.06B | |
$49,967,154 | 11 | 62.08% | $1.18B | |
$11,541,901 | 10 | 8.07% | $1.04B | |
$5,794,001 | 10 | 23.26% | $1.02B | |
$1,580,951 | 9 | -14.18% | $1.08B | |
$93,268,646 | 8 | -37.22% | $1.15B | |
$160,798,946 | 8 | -3.92% | $993.02M | |
$46,235,722 | 6 | -31.77% | $1.01B | |
$19,420,853 | 5 | 4.35% | $1.07B | |
$33,624,000 | 2 | -50.37% | $996.99M |
| Increased Positions | 76 | +50.67% | 15M | +13.39% |
| Decreased Positions | 61 | -40.67% | 19M | -17.09% |
| New Positions | 34 | New | 4M | New |
| Sold Out Positions | 22 | Sold Out | 14M | Sold Out |
| Total Postitions | 165 | +10% | 104M | -3.7% |
| Baker Bros. Advisors Lp | $102,671.00 | 9.21% | 27.53M | 0 | 0% | 2025-09-30 |
| Capital World Investors | $49,837.00 | 4.47% | 13.36M | 0 | 0% | 2025-09-30 |
| Baillie Gifford & Co | $38,878.00 | 3.49% | 10.42M | +62,962 | +0.61% | 2025-09-30 |
| Two Sigma Investments, Lp | $19,303.00 | 1.73% | 5.18M | +1M | +25.89% | 2025-09-30 |
| Two Sigma Advisers, Lp | $17,904.00 | 1.61% | 4.8M | +729,600 | +17.93% | 2025-09-30 |
| Arrowmark Colorado Holdings Llc | $15,312.00 | 1.37% | 4.11M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $13,584.00 | 1.22% | 3.64M | -39,015 | -1.06% | 2025-09-30 |
| Renaissance Technologies Llc | $12,536.00 | 1.12% | 3.36M | +53,300 | +1.61% | 2025-09-30 |
| Morgan Stanley | $10,415.00 | 0.93% | 2.79M | +2M | +180.07% | 2025-09-30 |
| Tang Capital Management Llc | $9,698.00 | 0.87% | 2.6M | 0 | 0% | 2025-09-30 |